On the 16th, cosmetic raw material specialist NFC announced that it has signed a non-disclosure agreement (NDA) with large brands in North America to supply LACTO‑PDRN and strengthen its overseas business.
LACTO‑PDRN is a third-generation fermentation-based PDRN derived from lactic acid bacteria, known for its excellent efficacy in skin regeneration and anti-aging. It has the advantage of a low molecular DNA structure with higher bioavailability and absorption rates than existing salmon and plant-derived PDRN. Clinical results confirming significant effects on skin elasticity, wrinkle improvement, and shine enhancement have been observed. It is expected to be actively utilized in medical and cosmetic applications.
NFC has successfully commercialized fermentation PDRN derived from lactic acid bacteria in collaboration with a domestic bio company that possesses expertise and technology in lactic acid fermentation.
Recently, as the trend of eco-friendly consumption leads the global market, the non-animal-derived raw material LACTO‑PDRN is gaining attention in the North American and European markets as a sustainable beauty solution. This is evaluated as an element that can concretize a brand's philosophy and sustainability strategy beyond the simple eco-friendliness of the raw material.
It is reported that many global cosmetic brands considering the launch of high-function skincare products utilizing LACTO‑PDRN have reached out to NFC.
A representative from NFC noted, "Currently, we have concluded multiple NDAs with large brands in North America" and said, "We have started joint research and development (R&D) for new product development with some partner companies." He added, "We are in discussions to include LACTO‑PDRN in each corporation's product lines, and we expect to launch products in the second half of this year or early next year."
He also emphasized, "This strategic NDA in the North American market is a partnership that starts from the product planning stage, rather than a simple supply contract," stating, "We will secure a leading position in the global market based on the competitiveness of commercialized LACTO‑PDRN."
The potential for utilizing LACTO‑PDRN is not limited to the cosmetics field. The company's internal researchers explain that the raw material can be a multi-platform bio material that can expand into various areas such as dermatology clinics, high-functionality aesthetic care, and premium healthcare products. Internally, they are researching ways to convert it for use in specialized clinic products, highly concentrated ampoules, and procedure support products.
NFC plans to participate in the 'Make Up New York 2025' fair in New York, USA, in September, where it will showcase various product concepts that apply LACTO‑PDRN, aiming to accelerate new buyer discovery and local market entry.